Logo image of ALGAE.PA

FERMENTALG (ALGAE.PA) Stock Fundamental Analysis

Europe - EPA:ALGAE - FR0011271600 - Common Stock

0.4465 EUR
-0.01 (-2.93%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

3

ALGAE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. ALGAE may be in some trouble as it scores bad on both profitability and health. ALGAE is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALGAE has reported negative net income.
In the past year ALGAE has reported a negative cash flow from operations.
ALGAE had negative earnings in each of the past 5 years.
ALGAE had a negative operating cash flow in each of the past 5 years.
ALGAE.PA Yearly Net Income VS EBIT VS OCF VS FCFALGAE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -24.56%, ALGAE is not doing good in the industry: 89.55% of the companies in the same industry are doing better.
ALGAE has a worse Return On Equity (-38.02%) than 83.58% of its industry peers.
Industry RankSector Rank
ROA -24.56%
ROE -38.02%
ROIC N/A
ROA(3y)-23.5%
ROA(5y)-19.63%
ROE(3y)-36.23%
ROE(5y)-31.43%
ROIC(3y)N/A
ROIC(5y)N/A
ALGAE.PA Yearly ROA, ROE, ROICALGAE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

ALGAE has a Gross Margin of 20.94%. This is in the lower half of the industry: ALGAE underperforms 67.16% of its industry peers.
In the last couple of years the Gross Margin of ALGAE has declined.
ALGAE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.82%
GM growth 5YN/A
ALGAE.PA Yearly Profit, Operating, Gross MarginsALGAE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

3

2. Health

2.1 Basic Checks

ALGAE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALGAE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALGAE has been increased compared to 5 years ago.
The debt/assets ratio for ALGAE has been reduced compared to a year ago.
ALGAE.PA Yearly Shares OutstandingALGAE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ALGAE.PA Yearly Total Debt VS Total AssetsALGAE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.36, we must say that ALGAE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.36, ALGAE is not doing good in the industry: 76.12% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.12 indicates that ALGAE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.12, ALGAE is in the better half of the industry, outperforming 79.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACCN/A
WACC6.07%
ALGAE.PA Yearly LT Debt VS Equity VS FCFALGAE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

ALGAE has a Current Ratio of 1.88. This is a normal value and indicates that ALGAE is financially healthy and should not expect problems in meeting its short term obligations.
ALGAE has a Current ratio (1.88) which is comparable to the rest of the industry.
A Quick Ratio of 1.83 indicates that ALGAE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.83, ALGAE belongs to the top of the industry, outperforming 80.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.83
ALGAE.PA Yearly Current Assets VS Current LiabilitesALGAE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.44% over the past year.
Looking at the last year, ALGAE shows a very strong growth in Revenue. The Revenue has grown by 59.05%.
ALGAE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.52% yearly.
EPS 1Y (TTM)55.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.36%
Revenue 1Y (TTM)59.05%
Revenue growth 3Y26.74%
Revenue growth 5Y43.52%
Sales Q2Q%20.35%

3.2 Future

Based on estimates for the next years, ALGAE will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.96% on average per year.
The Revenue is expected to grow by 39.99% on average over the next years. This is a very strong growth
EPS Next Y30.77%
EPS Next 2Y30.09%
EPS Next 3Y27.59%
EPS Next 5Y17.96%
Revenue Next Year13.04%
Revenue Next 2Y50.36%
Revenue Next 3Y56.76%
Revenue Next 5Y39.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALGAE.PA Yearly Revenue VS EstimatesALGAE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20M 40M 60M 80M 100M
ALGAE.PA Yearly EPS VS EstimatesALGAE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALGAE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALGAE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALGAE.PA Price Earnings VS Forward Price EarningsALGAE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALGAE.PA Per share dataALGAE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

ALGAE's earnings are expected to grow with 27.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.09%
EPS Next 3Y27.59%

More info and screens

0

5. Dividend

5.1 Amount

ALGAE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FERMENTALG

EPA:ALGAE (11/14/2025, 7:00:00 PM)

0.4465

-0.01 (-2.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-07 2025-10-07
Earnings (Next)01-12 2026-01-12
Inst Owners24.45%
Inst Owner ChangeN/A
Ins Owners2.02%
Ins Owner ChangeN/A
Market Cap40.11M
Revenue(TTM)12.78M
Net Income(TTM)-11.54M
Analysts84.44
Price Target0.73 (63.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-12.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.14
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 2.56
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.14
BVpS0.34
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.56%
ROE -38.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.94%
FCFM N/A
ROA(3y)-23.5%
ROA(5y)-19.63%
ROE(3y)-36.23%
ROE(5y)-31.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.82%
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.25%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.83
Altman-Z 1.36
F-Score6
WACC6.07%
ROIC/WACCN/A
Cap/Depr(3y)32.24%
Cap/Depr(5y)108.18%
Cap/Sales(3y)12.02%
Cap/Sales(5y)34.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.36%
EPS Next Y30.77%
EPS Next 2Y30.09%
EPS Next 3Y27.59%
EPS Next 5Y17.96%
Revenue 1Y (TTM)59.05%
Revenue growth 3Y26.74%
Revenue growth 5Y43.52%
Sales Q2Q%20.35%
Revenue Next Year13.04%
Revenue Next 2Y50.36%
Revenue Next 3Y56.76%
Revenue Next 5Y39.99%
EBIT growth 1Y15.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.18%
EBIT Next 3Y33.56%
EBIT Next 5Y22.54%
FCF growth 1Y49.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.34%
OCF growth 3YN/A
OCF growth 5YN/A

FERMENTALG / ALGAE.PA FAQ

What is the ChartMill fundamental rating of FERMENTALG (ALGAE.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALGAE.PA.


What is the valuation status of FERMENTALG (ALGAE.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to FERMENTALG (ALGAE.PA). This can be considered as Overvalued.


Can you provide the profitability details for FERMENTALG?

FERMENTALG (ALGAE.PA) has a profitability rating of 0 / 10.


What is the financial health of FERMENTALG (ALGAE.PA) stock?

The financial health rating of FERMENTALG (ALGAE.PA) is 3 / 10.